Patient-reported Outcomes of Laparoscopic Magnetic Sphincter Augmentation for Gastro-oesophageal Reflux Disease

Overview

Journal Ann R Coll Surg Engl

Specialty General Surgery

Date 2023 Aug 23

PMID 37609688

Authors

D Nehra

Cdm Clements

S L Bezzaa

Y Tabbakh

C M Walsh

Affiliations

Soon will be listed here.

Abstract

Introduction: Gastro-oesophageal reflux disease (GORD) is a chronic progressive disease, associated with substantial clinical and economic burden. Proton pump inhibitors (PPIs) are considered first-line treatment; however, there are concerns around the long-term impact of their usage. Surgical treatment with Nissen fundoplication can be considered but, because of the potential side effects, few patients undergo surgery and there remains a substantial therapeutic gap within the current treatment pathway. Laparoscopic magnetic sphincter augmentation (MSA) using the LINX device is an alternative surgical approach.

Methods: The objective of this study was to investigate patient-reported outcomes following laparoscopic MSA surgery using the LINX device in a UK setting. A retrospective questionnaire obtained data regarding postoperative symptoms, medication use and patient satisfaction.

Results: Out of 131 patients surveyed, 97 responses were received, with a minimum follow-up time of 1 year. In those who reported heartburn and regurgitation preoperatively, improvement was reported in 93% (84/90) and 90% (86/96) of patients, respectively. Eighty-eight per cent (73/83) of patients were able to completely stop or reduce their medication by at least 75%. Seventy-seven per cent (73/95) of patients were "very satisfied" or "satisfied".

Conclusions: This study is the first to present patient-reported outcomes of MSA using the LINX device for patients with GORD in the UK. It demonstrates that the device has favourable outcomes and could effectively bridge the current therapeutic gap that exists between PPI medication and Nissen fundoplication.

References

Fuchs K, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E . EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014; 28(6):1753-73. DOI: 10.1007/s00464-014-3431-z. View

Gomm W, von Holt K, Thome F, Broich K, Maier W, Fink A . Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. JAMA Neurol. 2016; 73(4):410-6. DOI: 10.1001/jamaneurol.2015.4791. View

Lipham J, Taiganides P, Louie B, Ganz R, DeMeester T . Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2014; 28(4):305-11. DOI: 10.1111/dote.12199. View

Sachs G . Improving on PPI-based therapy of GORD. Eur J Gastroenterol Hepatol. 2001; 13 Suppl 1:S35-41. View

Thong B, Ima-Nirwana S, Chin K . Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved. Int J Environ Res Public Health. 2019; 16(9). PMC: 6540255. DOI: 10.3390/ijerph16091571. View

Katzka D, Kahrilas P . Advances in the diagnosis and management of gastroesophageal reflux disease. BMJ. 2020; 371:m3786. DOI: 10.1136/bmj.m3786. View

Lagergren J, Bergstrom R, Lindgren A, Nyren O . Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340(11):825-31. DOI: 10.1056/NEJM199903183401101. View

Saino G, Bonavina L, Lipham J, Dunn D, Ganz R . Magnetic Sphincter Augmentation for Gastroesophageal Reflux at 5 Years: Final Results of a Pilot Study Show Long-Term Acid Reduction and Symptom Improvement. J Laparoendosc Adv Surg Tech A. 2015; 25(10):787-92. PMC: 4624249. DOI: 10.1089/lap.2015.0394. View

Bonavina L, Saino G, Bona D, Lipham J, Ganz R, Dunn D . Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg. 2008; 12(12):2133-40. DOI: 10.1007/s11605-008-0698-1. View

10.

Maret-Ouda J, Markar S, Lagergren J . Gastroesophageal Reflux Disease: A Review. JAMA. 2020; 324(24):2536-2547. DOI: 10.1001/jama.2020.21360. View

11.

Schwameis K, Schwameis M, Zorner B, Lenglinger J, Asari R, Riegler F . Modern GERD treatment: feasibility of minimally invasive esophageal sphincter augmentation. Anticancer Res. 2014; 34(5):2341-8. View

12.

Reynolds J, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham J . Laparoscopic Magnetic Sphincter Augmentation vs Laparoscopic Nissen Fundoplication: A Matched-Pair Analysis of 100 Patients. J Am Coll Surg. 2015; 221(1):123-8. DOI: 10.1016/j.jamcollsurg.2015.02.025. View

13.

Rubenstein J, Scheiman J, Sadeghi S, Whiteman D, Inadomi J . Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am J Gastroenterol. 2010; 106(2):254-60. PMC: 3901355. DOI: 10.1038/ajg.2010.470. View

14.

Ganz R, Peters J, Horgan S, Bemelman W, Dunst C, Edmundowicz S . Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013; 368(8):719-27. DOI: 10.1056/NEJMoa1205544. View

15.

Riegler M, Schoppman S, Bonavina L, Ashton D, Horbach T, Kemen M . Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2014; 29(5):1123-9. DOI: 10.1007/s00464-014-3772-7. View

16.

Bonavina L, DeMeester T, Fockens P, Dunn D, Saino G, Bona D . Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg. 2010; 252(5):857-62. DOI: 10.1097/SLA.0b013e3181fd879b. View

17.

Leonard J, Marshall J, Moayyedi P . Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007; 102(9):2047-56. DOI: 10.1111/j.1572-0241.2007.01275.x. View

18.

Finks J, Wei Y, Birkmeyer J . The rise and fall of antireflux surgery in the United States. Surg Endosc. 2006; 20(11):1698-701. DOI: 10.1007/s00464-006-0042-3. View

19.

Bonavina L, Saino G, Bona D, Sironi A, Lazzari V . One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg. 2013; 217(4):577-85. DOI: 10.1016/j.jamcollsurg.2013.04.039. View

20.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007; 4(10):e296. PMC: 2020495. DOI: 10.1371/journal.pmed.0040296. View